To assess the feasibility of using an ultra-low dose ( @ mmol/kg of body weight -LSB- BW -RSB- ) of high relaxivity contrast agent for late gadolinium enhancement ( LGE ) imaging in patients with acute myocardial infarction ( AMI ) .